Last reviewed · How we verify
NCT03845647
Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma.
NA trial testing contralateral central lymph node dissection in Lymph Node Dissection in 50 participants. Status unknown.
28 December 2020
Quick facts
| Lead sponsor | Fifth Affiliated Hospital, Sun Yat-Sen University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 February 2019 |
| Primary completion | 28 December 2020 |
| Estimated completion | 28 December 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- contralateral central lymph node dissection
Conditions studied
- Lymph Node Dissection — all drugs for Lymph Node Dissection →
- Lymph Node Metastases — all drugs for Lymph Node Metastases →
- Differentiated Thyroid Carcinoma — all drugs for Differentiated Thyroid Carcinoma →
Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Who can join
Adults 18 to 65, any sex, with Lymph Node Dissection or Lymph Node Metastases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There are so many contradictions over central lymph node dissection in unilateral cN0(Clinically N0) differentiated thyroid carcinoma.In order to provides a new theoretical basis for the operation of central lymph node in cN0(Clinically N0) differentiated thyroid cancer,researchers are going to complete this study to evaluate the significance of contralateral central lymph node dissection in unilateral cN0(Clinically N0) differentiated thyroid carcinoma.At the same time,it may play a certain impact on the revision of surgical guidelines for differentiated thyroid cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03845647
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lymph Node Dissection
Currently open trials in the same condition.
- NCT07321210 — Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma · NA · recruiting
- NCT06634979 — Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm · NA · recruiting
Other Fifth Affiliated Hospital, Sun Yat-Sen University trials
Trials by the same sponsor.
- NCT06079931 — The Efficacy of Babaodan Capsules in Preventing Radiation Pneumonia · Phase 2 · unknown
- NCT06525025 — Building a Traditional Chinese Medicine Clinical Diagnosis and Treatment Database · not yet recruiting
- NCT06060782 — Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine · Phase 1 · recruiting
- NCT06220552 — The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma · Phase 2 · recruiting
- NCT06147947 — Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03845647 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fifth Affiliated Hospital, Sun Yat-Sen University
- Last refreshed: 24 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03845647.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing